Vinculin is a conserved actin binding protein localized in focal adhesions and cell-cell junctions.
Introduction
Cell spreading is a complex process requiring a bidirectional transmembrane linkage between the extracellular matrix and the actin cytoskeleton. Most cell-substrate interactions are mediated by members of the integrin superfamily of transmembrane adhesion receptors (Hynes, 2002) .
Integrin-activating ligands trigger changes in receptor conformation and receptor clustering which in turn activate signaling events leading to the assembly of focal complexes and actin filament networks (Critchley, 2000; Emsley et al., 2000; Geiger et al., 2001; Kim et al., 2003; Liu et al., 2000; Ridley et al., 2003) . Vinculin is one of the first actin binding proteins recruited into focal complexes, and subsequently focal adhesion plaques (Geiger et al., 1980; Zaidel-Bar et al., 2003) . Vinculin is composed of a large 95-kDa globular head and a 30-kDa tail linked by a short proline-rich sequence (Coutu and Craig, 1988) . The three regions serve as docking sites for several proteins. Actin and paxillin bind to sequences located in the vinculin tail domain (Goldmann et al., 1998; Huttelmaier et al., 1997; Menkel et al., 1994; Wood et al., 1994) . Talin and α-actinin bind to the vinculin head domain while members of the Ena/VASP and ponsin/ArgBP52/vinexin families, as well as the Arp 2/3 complex, interact with the proline-rich region in vinculin (Critchley, 2000; DeMali et al., 2002; Kawabe et al., 1999; Mandai et al., 1999) .
Biochemical and structural studies established that vinculin exists in at least two distinct conformations dependent upon an intramolecular interaction between its head and tail domains (Bakolitsa et al., 2004; Bakolitsa et al., 1999; Borgon et al., 2004; Izard et al., 2004; Johnson and Craig, 1994; Winkler et al., 1996) . Binding of the head to the tail domain results in a "closed conformation" that limits accessibility of vinculin-binding proteins to their docking sites. It is currently thought that acidic phospholipids, which bind to the vinculin tail domain, transiently disrupt head-tail interactions and enable the binding of ligands such as talin, VASP, and protein kinase Cα (PKCα), to their respective sites (Bakolitsa et al., 2004; Gilmore and Burridge, 1996; Huttelmaier et al., 1998; Steimle et al., 1999; Weekes et al., 1996; Ziegler et al., 2002) .
PKCα phosphorylates vinculin on at least two serine residues in positions 1033 and 1045; the role of the phosphorylation is currently not fully understood (Ziegler et al., 2002) . Izard et al recently reported that binding of talin derived peptides to vinculin triggered marked conformational changes in vinculin and head-tail displacement . These 4 observations raised the possibility that various inputs might either activate specific repertories of vinculin-dependent signaling events or determine the duration of downstream signals.
Vinculin null embryos did not survive past embryonic day 10 demonstrating that vinculin plays a key role during embryonic development (Xu et al., 1998a) . The role of vinculin relative to cell spreading, however, is currently not fully understood. Vinculin null fibroblasts assembled focal adhesion plaques, and yet, spread poorly on fibronectin (Xu et al., 1998b) , suggesting that vinculin might regulate the dynamics of actin filament assembly. The interaction between vinculin and Arp 2/3 uncovered by DeMali and Burridge (DeMali et al., 2002) provided insight into one mechanism by which vinculin may execute its regulatory function. More recently Subauste et al (Subauste et al., 2004) reported that vinculin modulates the interaction between paxillin and FAK, which in turn affected ERK signaling required for cell survival and motility.
These findings revealed a previously unappreciated layer of interactions involving vinculin.
Vinculin was one of the first identified tyrosine phosphorylation substrates of v-Src, the transforming oncogene of Rouse Sarcomma virus (Sefton et al., 1981) . The v-Src dependent phosphorylation sites in vinculin were not mapped (Ito et al., 1983) . Tyrosine phosphorylation of vinculin was observed in platelets stimulated by Ca +2 (Vostal and Shulman, 1993 ) and more recently in leukotriene D(4) treated intestinal epithelial cells (Massoumi and Sjolander, 2001 ).
In an effort to characterize a protein of 120-kD that is heavily tyrosine phosphorylated in spread platelets we identified the protein as vinculin. We also found that the phosphorylation of vinculin in platelets is regulated by Src kinases. The phosphorylation of vinculin was reconstituted in COS-7 cells cotransfected with c-Src and the tyrosine phosphorylation sites were mapped to residues 1065 and 100. A vinculin double mutant protein, Y100F/Y1065F, was less effective than wild type vinculin in rescuing the spreading defect of vinculin null cells on fibronectin.
These findings suggest that the phosphorylation of vinculin by Src kinases might affect early events in cell spreading.
Materials and Methods
Antibodies and Cell lines. mAbs 4G10 and PY-20 were purchased from, respectively, Upstate
Biotechnology and Transduction Laboratories. The mAbs to human vinculin (hVin-1, V9131) or to chicken vinculin (VIN-115) were from Sigma. The mAb against 6-His was purchased from
Qiagen. The vinculin-null mouse embryo fibroblasts (Vin -/-) (Xu et al., 1998a) were a gift from E. Adamson (Burnham Institute, La Jolla, CA). The Vin -/-clone used in this study was identical to the clone used by DeMali and Burridge (DeMali et al., 2002) . The COS-7 and the NIH 3T3 cells were from the American Tissue Type Culture Collection.
Platelet Isolation. Human platelets were isolated by gel filtration as previously described (Haimovich et al., 1993) . Platelets were lysed immediately or were adhered for 1 hr to fibrinogen ((100 µg/ml) Sigma)) coated onto the surface of electrically untreated polystyrene plates as described (Haimovich et al., 1993) . Where indicated, platelets were treated for 30 min with 5 µM PP2 (Calbiochem) prior to exposure to the fibrinogen coated plates. Unstimulated and adherent platelets were lysed with 2% SDS in buffer containing 66 mM Tris pH 7.4, 1 mM vanadate, and 1 mM PMSF.
Isolation and characterization of a ~120-kD platelet phosphoprotein. Platelets were purified by gel-filtration from 5 units of outdated platelets (purchased from the New Jersey Blood Bank). To activate the platelets and to induce aggregation, the platelet suspension was stirred vigorously for 20 min with 10 nM of phorbol 12-myristate 13-acetate (PMA). The resulting platelet aggregates were collected by 5 min centrifugation at 800 x g. The platelet pellet was resuspended in 6 ml of lysis buffer containing 50 mM Tris-HCl, pH 8.0, 0.02% Triton X-100, 1 mM EGTA, 1 mM Na 3 VO 4 and 1 mM phenylmethylsulfonyl fluoride (PMSF). The cell suspension was sonicated briefly to disrupt the aggregates. All subsequent steps were carried out at 4 0 C. The lysate was cleared by 20 min centrifugation at 17,000 x g and the resulting supernatant was loaded onto a Sephacryl-300 HR column (1.6 x 70 cm). Fractions were collected at a constant flow of 0.32 ml/min. Proteins were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. The pattern of tyrosine phosphorylated proteins in each fraction was analyzed by immunoblotting and probing with mAb 4G10. Fractions 6-11 were combined and dialysis-concentrated against 50 (Izaguirre et al., 1999) .
Immunoprecipitation of phosphorylated vinculin from platelets. Fibrinogen adherent platelets were lysed in RIPA buffer (1% Triton X-100, 1% deoxycholic acid, 10 mM Tris-HCl, pH 7.2, 158 mM NaCl, 0.1% sodium dodecyl sulfate,1 mM Na 3 VO 4 and 1 mM PMSF). The lysates were precleared for 1 hr with 40 µl of protein A/G agarose beads followed by an overnight incubation with mAb PY-20. Antibody-antigen complexes were precipitated with 50 µl of protein A/G agarose beads, eluted with sample buffer, and analyzed by SDS-PAGE.
Proteolytic Digestion of Platelet vinculin. Activated platelet lysates were resolved by SDS-PAGE on a 7.5% T acrylamide gel (18 cm long, 1.5 mm thick). One half of the gel was blotted onto nitrocellulose. To verify the phosphorylation of vinculin and its position on the gel the membrane was probed sequentially with the mAbs to vinculin and to phosphotyrosine. The second half of the gel was stained with Coomassie Blue R-250 for 2 hr and destained overnight.
The gel was rehydrated in water until it regained its original dimension. The area of the gel containing vinculin was excised and placed in a microcentrifuge tube. Each gel piece was washed for 5 min with 300 µl of 50% acetonitrile and then for 30 min each with the same volumes of 50% acetonitrile , 50 mM NH 4 HCO 3 , pH 8.0, followed by 50% acetonitrile , 10 mM Jolla , CA ). The Y100F/Y1065F double mutant was generated by two cycles of mutagenesis.
The introduction of the expected mutations was confirmed by DNA sequencing. The same approach was also used to introduce the Y100F, Y1065F, and Y100F/Y1065F substitutions in vinculin cloned into the pEGFP vector (kindly provided by Sue Craig). To introduce glutamic acid substitutions in place of the tyrosine residues at position 100 and 1065, the TAT in the 8 appropriate positions were changed to GAG by site directed mutagenesis. The double mutant Y100E/ Y1065E was generated using two cycles of mutagenesis.
Expression of recombinant proteins in COS-7 cells. Cells were transfected using the Lipofectamine Plus reagents (Invitrogen) following the protocol recommended by the vendor.
Briefly, cells cultured in 10 cm dishes were cotransfected with 3 µg of wild-type or mutant vinculin cDNAs and 1 µg of a constitutivly active c-Src cDNA (Y529F) (kindly provided by David Schlaepfer, Scripps Institute). Vanadate (1 mM) prepared as described (Izaguirre et al., 2001 ) was added to the cell culture medium 48 hr after transfection. The cells were cultured in the presence of vanadate for 24 h prior to analysis. Proteins were immunoprecipitated as previously described (Izaguirre et al., 2001) . To verify the antibody specificity, COS-7 cells were transfected with recombinant wild-type and mutant vinculin cDNAs as described above and lysates containing 500 µg/ml protein were subjected to immunoprecipitation with an antibody to the His tag. The immunoprecipitated proteins were resolved by SDS-PAGE and were Western blotted with the anti-vinculin [pY1065] antibody at a final concentration of 0.2 µg/ml. For Western blotting of total platelet lysates, the antibodies were first preabsorbed against unstimulated platelet lysates resolved by SDS-PAGE and then subjected to Western blotting as indicated above. Antibody specificity was also verified by peptide competition for which the anti-vinculin [pY1065] antibody (6 µg) was first incubated for 1 hr at RT with the phosphopeptide immunogen (60 µg) (BioSource International) in a final volume of 70 µl. The treated antibody was the used in Western blotting of platelet lysates.
In Vitro Src Kinase Assay. The expression plasmids encoding the His-tagged chicken vinculin head-(V1-851) and tail-(V884-1066) domains were described (Johnson and Craig, 2000) and were kindly provided by Sue Craig, John Hopkins University. Fusion proteins were produced in Escherichia coli BL21(DE3) cells treated with IPTG and purified as described (Johnson and Craig, 2000) . His tagged-vinculin tail or head domains (1µg each) were incubated with 7.5 unit/sample of constitutivly active c-Src kinase (Upstate Biotechnology) in the presence of 10 µCi of (γ-33 P)ATP in 25 µl of phosphorylation buffer (20 mM MOPS, pH 7.4, 5 mM MnCl 2 , 5 mM MgCl 2 , 1 mM DTT, 0.5 mM Sodium Vanadate). Phosphorylation was carried out for 15 min at 37 0 C. Reactions were terminated by the addition of Laemmli's sample buffer and heating for 5 min at 100˚C. Proteins were resolved by SDS-PAGE and transferred to a PVDF membrane.
Incorporation of (γ-33 P)ATP was visualized by autoradiography. To immunodetect the recombinant vinculin tail and head domains, respectively, membranes were probed with the mAbs to His and to vinculin.
Expression and purification of S-Transferase fusion proteins. The plasmid encoding the glutathione S-transferase (GST) tagged chicken vinculin head domain (GST/V1-855) (Johnson and Craig, 1994 ) was a generous gift from Susan W. Craig. The GST-tagged protein was expressed and purified as described (Johnson and Craig, 1994 ).
Vinculin's head-tail inteaction.
Purified His-vinculin-tail (His-Tail) (0.75 µg/sample) was incubated in the presence or absence of c-Src and the in vitro kinase assay was carried out as described above. Following the kinase reaction, the total volume of the sample was adjusted to 450 µl with TEEAN buffer containing 0.5% CHAPS, 0.1 mM Na3VO4, and 1 mM PMSF. The
Ni-NTA agarose beads were collected by a brief centrifugation and washed twice to remove the c-Src kinase. The resulting phosporylated and unphosphorylated His-tail proteins immobilized on Ni-NTA agarose beads were incubated for 3 h at 25ºC with purified GST/V1-head at the indicated concentration. Incubations (400 µl) were performed in TEEAN buffer supplemented with 0.5 mM β-mercaptoethanol and 1% bovine serum albumin. The samples were collected by brief centrifugation and washed four times in TEEAN. To elute the bound proteins, the Ni-NTA agarose pellets were heated in electrophoresis sample buffer. Eluted proteins were subjected to SDS-PAGE. Phosphorylation of the vinculin tail domain was analyzed by autoradiography and immunoblotting.
Vinculin-actin cosedimentation assay. To obtain unphosphorylated-and phosphorylatedvinculin, respectively, COS-7 cells were cotransfected with cDNAs encoding for wild type vinculin and c-Src and were either untreated or treated with vanadate as described above. The
His-tagged recombinant proteins in the phosphorylated and unphosphorylated form were purified on Ni-agarose columns as previously described (Izaguirre et al., 2001) . Actin (1.6 µM;
Cytoskeleton Inc. Denver, CO) and vinculin (0.05 µM) were incubated for 2 hrs at room temperature in a final volume of 250 µl containing 1.5 mM Tris pH 8.0, 0.04 mM CaCl 2 , 0.1 mM DTT, 100 mM KCl, 2 mM MgCl 2 , 1 mM ATP, 1 mM PMSF, and 0.1 mM Na 3 VO 4 . An aliquot (50 µl) representing the total protein content was removed from each sample prior to the sedimentation. The samples (200 µl each) were sedimented for 30 min at 95,000 x g (Steimle et al., 1999) in a Sorvall Discovery M150 SE Microultraspeed centrifuge using the S120AT3 rotor.
The supernatants were separated from the pellets, and the pellets were resuspended in 50 µl of SDS-PAGE sample buffer. Samples (35 µl each) representing a fraction of the initial reaction mix and the supernatant, and the entire pellet, were resolved by SDS-PAGE and Western blotting with the indicated antibodies.
Vinculin null cells spreading assay. The vinculin-null mouse embryo fibroblasts (Vin -/-) were maintained in DMEM supplemented with 10% FBS and cultured in 5% CO2 at 37ºC. Control cells were only transfected with a vector encoding for a puromycin resistant gene (pPUR, BD Biosciences Clontech, CA). All other groups were cotransfected with the pPUR vector plus GFP tagged-vinculin constructs at a ratio of 4:1. The cells were treated with puromycin at a concentration of 2 µg/ml starting at 24 hrs post transfection. The puromycin resistant cultures (we did not select clones) were propagated and expanded for about two weeks. To determine the level of expression of the recombinant proteins, lysates containing 20 µg protein were subjected to Western probing with the mAb to human vinculin.
To determine the effect of reconstituted vinculin on cell spreading, puromycin-resistant cell populations were trypsinized and replated onto fibronectin (10 µg/ml) (Calbiochem, La Jolla, CA) coated surfaces for 2 hrs. The cultures were fixed for 20 min with 3.7% formaldehyde, washed three times with PBS and examined by light microscopy using a Nikon Eclipse TE200 microscope equipped with a 20X/0.45 objective. For each cell population, a total of at least 500 cells distributed in six randomly selected fields were scored as either spread or round.
Experiments were repeated three times. Data represent the average ±S.D. The data were analyzed using an unpaired t-test. The statistical analysis was performed using the StatView® software from Abacus Concepts (Berkeley, CA).
Immunolocalization. NIH 3T3 cells were transfected with the GFP-tagged vinculin constructs using the lipofectamine plus reagents. The cells were trypsinized at 24 hrs post-transfection and were replated for 24 hrs onto fibronectin (20 µg/ml) precoated glass coverslips. The cells were fixed, permeabilized for 10 min with 0.1% Triton-X-100 in PBS, and stained with Texas red ® -x phalloidin (1:100, Molecular Probes, Eugene, OR) in PBS containing 1% bovine serum albumin.
The cells were visualized using a Zeiss LSM 510 confocal microscope equipped with a 60X/1.4
water objective.
Results

Vinculin is tyrosine phosphorylated in spread and/or aggregated platelets.
Numerous proteins are tyrosine phosphorylated in activated platelets. Stable phosphorylation of several of these proteins, including phosphoproteins of 101-and 120-kD, as well as α-actinin (105-kD) ( Fig. 1 A lane 2), are only detected when platelets are fully spread on fibrinogen or when they are stimulated with 12-myristate 13-acetate (PMA) to form large aggregates. Our initial goal was to identify and characterize the phosphoprotein of 120-kD (pp120), which we partially purified from PMA stimulated outdated platelets (Izaguirre et al., 1999) . The activated platelets were lysed in buffer containing 0.02% Triton X-100 and soluble proteins were fractionated by sequential chromatography on a Sephacryl 300-HR and a DEAE-Sepharose column. Western blotting and probing with mAb 4G10 identified fractions containing pp120
( Fig. 1 B and C) . Fractions eluted off the DEAE-column that contained pp120 were combined and analyzed by Coomassie blue staining (Fig. 1 D) . The section of the gel containing pp120 was excised and analyzed by matrix assisted laser desorption ionization mass spectrometry (MALDI-MS). The mass of 18 peptides obtained from a tryptic digest of the sample matched the predicted mass of human vinculin-derived peptides (data not shown) indicating that pp120 is platelet vinculin.
Since phosphorylated vinculin was not immunoprecipitated using commercially available mAbs to vinculin (data not shown), we took a reversed approach and immunoprecipitated vinculin with a generic mAb to phosphotyrosine, PY-20. As shown in Fig. 1 E, a protein of 120-kD immunoprecipitated by mAb PY-20 was recognized by the mAb to vinculin by Western blotting.
To further confirm that vinculin is tyrosine phosphorylated in activated platelets, lysates of unstimulated platelets (Fig. 2 A) and fibrinogen adherent platelets (Fig. 2 B) were analyzed by two-dimension gels and Western blotting. The samples were resolved on parallel gels and transferred to PVDF membranes. The membranes were stained with Coomassie blue to visualize the general pattern of resolved proteins, destained, and probed with mAb 4G10 and the mAb to human vinculin. The region of the membrane containing vinculin is marked by a rectangle.
Platelet activation did not significantly alter the migration profile of most proteins detected by staining of the membranes with Coomassie blue (Fig. 2) . Vinculin migrated between pI 6.6 and 13 7.6. The broad migration pattern of vinculin reflects the multiple vinculin isoforms (five) identified in platelets (Bruin et al., 1991; Gravel et al., 1995) . Platelet spreading on fibrinogen did not significantly alter the electrophoretic mobility of vinculin. As expected, and previously shown (Izaguirre et al., 1999) , platelet activation resulted in a significant increase in the number and intensity of tyrosine phosphorylated proteins. The region of the membrane containing vinculin in the unstimulated platelets revealed only trace reactivity with mAb 4G10 (Fig. 2 A) . In contrast, two tyrosine phosphorylated proteins were noted in the same region of the membrane containing the fibrinogen-adherent platelet lysate (Fig. 2 B) . One tyrosine phosphorylated protein colocalized to the lower region of vinculin. A second tyrosine phosphorylated protein migrated immediately above and at the basic end of vinculin ( Fig. 2 B and C) . These findings established that vinculin is the only protein of 120 kD detected by this method of analysis exhibiting robust tyrosine phosphorylation in spread platelets.
Treatment of platelets with an inhibitor of Src kinases, PP2, prevents spreading and tyrosine phosphorylation of vinculin.
Vinculin was one of the first proteins found to be phosphorylated on tyrosine by the transforming gene product of Rous sarcoma virus, pp60 src (v-src) (Ito et al., 1983; Sefton et al., 1981) . Platelets express a high concentration of pp60 c-src (c-Src), the cellular homologue of v-Src (Golden et al., 1986) as well as several other Src kinase family members (Huang et al., 1991) .
To examine whether Src kinases regulate the phosphorylation of vinculin in platelets, platelets were treated with the inhibitor of Src kinases PP2 (Hanke et al., 1996) prior to adhesion to a fibrinogen-coated surface. Consistent with the results reported by Obergfell et al (Obergfell et al., 2002) , we also found that PP2 inhibited platelet spreading on fibrinogen (unpublished data).
Lysates of untreated platelets and PP2-pretreated platelets were analyzed by Western blotting. As shown in Fig. 3 A, the phosphorylation of vinculin was significantly reduced by PP2. In contrast, the phosphorylation of the 125 kD tyrosine phosphorylated protein migrating immediately above vinculin was only minimally affected by the inhibitor. These findings were confirmed by analysis of the PP2-pretreated platelet sample by 2-D gels. To enable accurate comparison between the PP2-treated and the untreated samples, the gel shown in Figure 3 B and those shown in Figure 2 were run in parallel and were processed at the same time. PP2 eliminated the reactivity of mAb 4G10 with pp120/vinculin but had no effect on the antibody reactivity with the 14 125 kD protein (Fig. 3 B) . These results established that pp120/vinculin and pp125 are two distinct proteins. These findings also provided a strong indication that the phosphorylation of vinculin on tyrosine in platelets is Src kinases dependent.
Vinculin is tyrosine phosphorylated on residues 100 and 1065.
Since platelets are not amenable to genetic manipulations, we sought to establish a model cell system in which the phosphorylation of vinculin could be further investigated. Because COS-7 cells are more resistant to vanadate than other cell types (e.g., NIH 3T3 cells), we constructed and expressed a recombinant His-tagged vinculin (His-vinculin) cDNA in these cells. Hisvinculin was successfully expressed in COS-7 cells but the protein was not phosphorylated either in the absence or the presence of vanadate (Fig. 4) . However, coexpression of His-vinculin with a constitutively active form of c-Src (Y529F) resulted in robust phosphorylation of vinculin. The phosphorylation of vinculin was only detected in cells treated with vanadate, indicating that in the absence of vanadate vinculin is rapidly dephosphorylated by an endogenous phosphatase.
Endogenous vinculin immunoprecipitated with the mAb to vinculin was also phosphorylated in vanadate treated cells cotransfected with c-Src (Fig. 4 C) . The phosphorylation of the endogenous vinculin was somewhat variable, and in some experiments (e.g., see Figure 5 ), it was barely detectable. Based on these findings, the phosphorylation of vinculin was examined in all subsequent experiments in COS-7 cells that were cotransfected with c-Src and treated with vanadate.
Vinculin contains 8 tyrosine residues (Fig. 5A) . Protease V8 cleaves vinculin in the proline-rich region (amino acid residues 837-879) to produce two major vinculin fragments: a 95-kD head domain and a 30-kD tail domain (Johnson and Craig, 1994) . Seven of the eight-tyrosine residues found in vinculin are located in the head domain. The only tyrosine residue located in the vinculin tail domain is positioned at residue 1065, one amino acid residue away from its carboxyl terminal end (Fig. 5 A) . To begin to map the phosphorylation site(s) in vinculin, fibrinogen adherent platelet lysates were resolved by SDS-PAGE, and the region of the gel containing phosphorylated vinculin was excised and subjected to in-gel digestion with carboxypeptidase Y, a proteolytic enzyme that removes amino acids from the carboxyl terminal end.
Carboxypeptidase Y eliminated the reactivity of mAb 4G10 with the phosphorylated vinculin within minutes (data not shown). These data provided the first indication that vinculin is phosphorylated on tyrosine residue 1065 in platelets.
To further investigate the phosphorylation sites in vinculin, the tyrosine in position 1065 was changed to phenylalanine by site directed mutagenesis (Fig. 5) . The mutant protein Y1065F
immunoprecipitated from COS-7 cells using the mAb to His exhibited significantly less phosphorylation than the wild-type protein suggesting that residue 1065 is a phosphorylation site (Fig. 5 B) . However, Western blotting of the proteins immunoprecipitation using the mAb to vinculin, revealed no difference in the level of phosphorylation between the recombinant wildtype vinculin and the Y1065F mutant (Fig. 5 D) . The simplest interpretation of these data was that vinculin is phosphorylated on more than one site. We speculate that the mAb to vinculin has a low affinity or does not recognize the population phosphorylated on residue 1065. This could explain why the mAb to vinculin failed to immunoprecipitate phosphorylated vinculin from activated platelets. To identify a second phosphorylation site in vinculin five additional tyrosine residues were individually changed to phenylalanines by site directed mutagenesis. The tyrosine residues chosen for site directed mutagenesis included residue 822 implicated as a phosphorylation site by other investigators (Goldmann and Ingber, 2002) , and residues 100, 160, 537, and 692. Pinna and Ruzzene proposed that Src kinase family members require a hydrophobic residue at n-1 for optimal phosphorylation (Pinna and Ruzzene, 1996) . Since a charged residue precedes the tyrosine residues in positions 107 and 144, these residues were not included in the first round of mutagenesis. The mutant proteins were coexpressed with c-Src in COS-7 cells. As shown in Fig. 5 B and 5D , the Y100F mutant exhibited less phosphorylation than wild-type vinculin. In contrast, the phosphorylation of Y822F (shown in Fig. 5 Furthermore, the antibody reactivity was completely blocked by the phosphopeptide immunogen.
These findings established that platelet vinculin is phosphorylated on tyrosine residue 1065. It remains to be determined whether platelet vinculin is phosphorylated on tyrosine residue 100 and/or any other site.
c-Src phosphorylates vinculin on residue 1065 in vitro.
To examine whether tyrosine residues 100 or 1065 are bona fide c-Src substrates, His-tagged vinculin tail (V884-1066) and head (V1-851) domain proteins expressed in E. Coli were purified on Ni
2+
-agarose columns and subjected to in vitro kinase assays in the presence of recombinant c-Src. The vinculin tail domain, but not the vinculin head domain, was phosphorylated by c-Src in vitro (Fig. 7) . These findings established that c-Src can phosphorylate vinculin on residue 1065 which is the only tyrosine residue in the tail domain. The mechanism by which vinculin is phosphorylated on residue 100 remains presently unclear. We have also found that intact vinculin was not phosphorylated by c-Src in vitro, raising the possibility that the tail residue is inaccessible to the kinase (unpublished data).
The phosphorylation of vinculin on tyrosine residue 1065 affects head-tail interaction.
Biochemical studies were the first to suggest that the vinculin head and tail domains are involved in intramolecular interactions (Johnson and Craig, 1994) . To examine whether the phosphorylation of vinculin on its tail domain affected head-tail interactions, GST-tagged head (GST-head) and His-tagged tail (His-tail) domain proteins were expressed and purified from IPTG-induced BL21 E. Coli. The His-tail was immobilized on Ni-NTA beads. Uncoated-and His-tail-coated beads were subsequently incubated with GST-head. As shown in Fig. 8 A and B, the GST-head did not bind to the beads in the absence of His-tail. In the presence of His-tail, however, the GST-head was pulled-down in a concentration-dependent manner reaching a plateau at a 1:1 ratio of His-tail to GST-head. These data indicated that this assay could quantify head-tail interactions when the His-tail is used in excess relative to the GST-head.
In the next set of experiments the His-tail was either not phosphorylated or was phosphorylated by c-Src in vitro. Unphosphorylated or phosphoryated His-tail proteins immobilized on Ni-NTA agarose beads were incubated with GST-head at a ratio of 3:1 (0.75 µg His-tail: 0.25 µg GSThead). As shown in Fig. 8 B, while the GST-head was effectively pulled-down by the unphosphorylated His-tail, the GST-head was not pulled-down by the phosphorylated His-tail.
These data indicated that the phosphorylation of vinculin on residue 1065 affects head tailinteraction.
The phosphorylation of vinculin on tyrosine residues 100 and 1065 does not affect the interaction between vinculin and actin in vitro.
An intramolecular association between the vinculin head and tail domains masks the actin binding site in vinculin (Johnson and Craig, 1995) and prevents the cosedimentation of intact vinculin with actin filaments. We considered the possibility that the phosphorylation of vinculin on tyrosine residues 100 and 1065 may alter the actin binding properties of intact vinculin. To test for this possibility recombinant vinculin in either their phosphorylated and unphosphorylated form were purified and subjected to cosedimentation with polymerized actin. The data shown in Figure 9 demonstrate that as previously shown for unphosphorylated vinculin, phosphorylated vinculin also failed to cosediment with actin filaments suggesting that the phosphorylation of vinculin by Src did not trigger a conformational change that was sufficient to expose the actin-binding site in vinculin.
Vinculin phosphorylation mutants localize to focal-adhesion plaques.
To examine whether the phosphorylation of vinculin affects its cellular localization, we used GFP-tagged wild type vinculin as a template to generate Y100F, Y1065F, and Y100F/Y1065F mutant constructs. The proteins were expressed in NIH 3T3 cells. The GFP-tagged wild type and mutant vinculin proteins localized to focal adhesion plaques indicating that the cellular localization of vinculin is not affected by its state of phosphorylation on tyrosine (Fig. 10) .
Further studies are required to determined whether the phosphorylation affects cell migration and/or the rate of assembly or turnover of focal adhesion plaques.
The phosphorylation of vinculin on tyrosine residues 100 and 1065 affects cell spreading.
To determine whether the phosphorylation of vinculin on tyrosine residues 100 and/or 1065 affects cell spreading, GFP-tagged wild-type and vinculin mutant proteins were expressed in vinculin null cells (Vin -/-) (Xu et al., 1998b) . Effort to identify vinculin reconstituted cells based on the fluorescence of the GFP tag was unsuccessful due to the fact that the fluorescence signal was very weak. To circumvent this problem, the vinculin null cells were cotransfected with GFPvinculin constructs and a vector encoding for a puromycin resistant gene (Gu et al., 1999) . A control group was transfected with only the puromycin encoding vector. Puromycin resistant populations were propagated and expanded for two weeks. The cultures transfected with the various vinculin constructs plus puromycin expressed equal levels of wild type and mutant vinculin proteins as determined by a Western blotting analysis of equal protein amounts (Fig. 11 A). To compare the spreading ability of vinculin null cells to cells expressing wild type vinculin or vinculin mutant proteins, the puromycin resistant cell populations were plated on fibronectin coated surfaces for 2 hrs, fixed and examined by light microscopy. As previously reported and shown in Fig. 11 
Discussion
Cell adhesion to the extracellular matrix triggers a rapid and dynamic assembly of multi-protein complexes that is driven by integrins. The protein complexes serve as a platform for coupling integrins to the actin polymerization and assembly machinery. The earliest identified multiprotein complexes, referred to as 'focal complexes' contain integrin(s), talin, paxillin, α-actinin, and low levels of vinculin and FAK (Zaidel-Bar et al., 2003) . The focal complexes are also rich in tyrosine phosphorylated proteins indicating that kinases are among the first proteins to be recruited and/or activated at these sites. In platelets, the α IIb β 3 -integrin receptor constitutivly interacts with Src kinases; the kinases are activated as a consequence of α IIb β 3 -activation and ligation (Arias-Salgado et al., 2003; Kralisz and Cierniewski, 1998; Obergfell et al., 2002) .
Platelets pretreated in vitro with an inhibitor of Src kinases, PP2, and murine platelets harvested from Src family kinase deficient mice, failed to spread on fibrinogen, the primary integrin α IIb β 3 extracellular matrix ligand (Obergfell et al., 2002) . Similarly, triple Src-, Yes-, and Fyn-kinase deficient fibroblasts exhibited impaired cell migration and spreading on fibronectin (Cary et al., 2002; Klinghoffer et al., 1999) . These findings established that Src kinases are key, early The data reported in this study demonstrate that endogenous vinculin is phosphorylated on tyrosine residue 1065 in spread platelets. The phosphorylation was not detected in unstimulated platelets or in platelets treated with the inhibitor of Src kinases, PP2. The phosphorylation of vinculin on tyrosine residue 1065 was reconstituted in vanadate treated cells cotransfected with wild-type vinculin and a constitutivly active c-Src kinase. Tyrosine residue 1065 was also phosphorylated by c-Src in vitro thus establishing that this residue is a bona fide Src kinases substrate. Using the reconstituted COS-7 system we identified a second phosphorylation site on residue 100. Unlike residue 1065, residue 100 was not phosphorylated by c-Src in vitro, raising the possibility that the phosphorylation of vinculin may be regulated by two, or more, distinct kinases. Importantly, we also found that while the single point mutant proteins (Y100F and Y1065F) were as effective as wild vinculin in rescuing the spreading defect of vinculin -/-cells on fibronectin, the double mutant protein (Y100F/Y1065F) was significantly less effective than wild type vinculin, or the single point mutants. Furthermore, a second double mutant protein carrying negative charges in place of the tyrosine residues in position 100 and 1065 (Y100E/Y1065E) was significantly more effective than wild type vinculin in rescuing the spreading defect of vinculin -/-cells on fibronectin. It is therefore possible that the activity of vinculin is optimal only when both sites are phosphorylated.
Biochemical and crystal structure data demonstrated that vinculin exists in closed and open conformations. Vinculin is held in an inactive, closed conformation by intramolecular interactions between its head and tail domains (Johnson and Craig, 1994 ) (Bakolitsa et al., 2004; Bakolitsa et al., 1999; Borgon et al., 2004; Izard et al., 2004) . The actin binding site in vinculin is masked when vinculin is in its closed conformation (Johnson and Craig, 1995) . Binding of acidic phospholipids to the vinculin tail domain affects head-tail interactions and converts vinculin to an active, ligand-binding competent, form (Gilmore and Burridge, 1996; Weekes et al., 1996) . Crystal structures recently resolved by Izard et al further revealed that binding of talin derived peptides to the vinculin head domain induces a marked conformation change in the vinculin head domain resulting in tail displacement . Binding of α-actinin to vinculin similarly affected vinculin's head-tail interaction . These observations established that the conversion of vinculin from a closed to an open conformation is regulated by several, alternative mechanisms. Based on the observation that the phosphorylation of vinculin on tyrosine residue 1065 reduced head-tail interaction in vitro, we speculated that the phosphorylation of vinculin by Src kinases could also positively regulate the activation state of vinculin. In at least one analogous situation, the valosin-containing protein (VCP) was found to be phosphorylated on tyrosine residue 805, the penultimate residue in the protein (Egerton et al., 1992) . The phosphorylation of VCP on residue 805 disrupted intramolecular head-tail interactions, which in turn exposed a nuclear-targeting sequence in the VCP head domain (Madeo et al., 1998) . Similarly, the phosphorylation of ezrin on a threonine residue caused conformational changes that unmasked both membrane and actin binding sites in the protein 22 (Fievet et al., 2004) . Here we show that phosphorylated vinculin did not cosediment with polymerized actin, suggesting that the actin binding site in vinculin remained masked despite the phosphorylation. It thus appears that the primary function of the phosphorylation of vinculin on serine residues 1033 and 1045 (Ziegler et al., 2002) or tyrosine residues 100 and 1065 is not to modulate the interaction between vinculin and actin. The change(s) in conformation brought about by the phosphorylation might impact the interaction of vinculin with other proteins, and/or determines how long vinculin is in an open conformation. The recent study by Subauste et al (Subauste et al., 2004) suggesting that the vinculin tail domain could modulate the interaction between paxillin and FAK highlights one mechanism by which a change in the tail conformation may affect cellular responses.
Vinculin is a well-established constituent of focal adhesion plaques. Recent studies revealed that the localization of some focal adhesion components is regulated by their state of phosphorylation. Interestingly, FAK and α-actinin, two of the proteins thought to directly interact with integrins (Otey et al., 1990; Schaller et al., 1995) , were excluded from focal adhesion plaques when phosphorylated on tyrosine residues (Katz et al., 2003; von Wichert et al., 2003) . These observations raised the possibility that the density of proteins such as FAK and α-actinin within the plaque is regulated. We have no evidence at the present time that the localization of vinculin to focal adhesion plaques is similarly affected by its state of phosphorylation; in fact, two lines of evidence argue against this possibility. First, we found that the vinculin double mutant Y100F/Y1065F and Y100E/Y1065E (data not shown) localized to focal adhesion plaques. In addition, Volberg et al reported that vinculin localized to focal adhesion plaques in Src, Yes, and Fyn triple null cells (Volberg et al., 2001) . These findings, however, do not exclude the possibility that the phosphorylation of vinculin by Src kinases affects the dynamics of its recruitment and/or residency time within the early focal complexes, where it may play an important role in regulating the assembly of actin filaments, possibly through an Arp 2/3 dependent mechanism (DeMali et al., 2002) .
Ziegler et al (Ziegler et al., 2002) proposed that the phosphorylation of vinculin by protein kinase C may regulate the incorporation of vinculin into nascent cell adhesion complexes. In fact, it is possible that both Src and protein kinase C enzyme families regulate the dynamics of vinculin assembly into plaques. Indeed, treatment of platelets with phorbol 12-myristate 13-acetate (PMA), a protein kinase C activator, triggered robust phosphorylation of vinculin, while treatment of the platelets with bisindolylmaleimide, an inhibitor of protein kinase C (Toullec, 1991) , inhibited platelet spreading on fibrinogen as well as the phosphorylation of vinculin on tyrosine 1065 ( Zhiyong Zhang, Siang-Yo Lin, and Beatrice Haimovich, unpublished data) . It is also possible that as shown in T cells, protein kinase C regulates the activity of a Src kinase family member(s) (Niu et al., 2003) . Further studies are required to determine whether platelet vinculin is phosphorylated on serine residues 1033 and 1045, and whether the phosphorylation on these sites is a prerequisite for the phosphorylation on tyrosine residue 1065.
The crystal structure of chicken vinculin tail domain (residues 879-1066), the human vinculin head (residues 1-258) and tail (residues 879-1066) domain complex, and that of intact vinculin were resolved (Bakolitsa et al., 1999 ) (Bakolitsa et al., 2004 Borgon et al., 2004; Izard et al., 2004) . In the intact vinculin residue 100 is fully exposed while residue 1065 is occluded by a stretch of amino acids derived from the proline rich region (Bakolitsa et al., 2004) . The fact that residue 1065 is buried, explains why intact vinculin was not phosphorylated by c-Src in vitro ( Zhiyong Zhang, Siang-Yo Lin, and Beatrice Haimovich, unpublished data) and is consistent with the possibility that the phosphorylation of vinculin by c-Src requires a priming input. The atomic structure of the vinculin tail domain revealed a bundle of five helices connected by short loops and packed in an anti-parallel orientation with the N-and C-terminal ends emerging from the same side of the bundle (Bakolitsa et al., 1999) . Extending from the last helix is a stretch of 21-amino acids, referred to as the C-terminal arm (1045-1066). Bakoltisa et al identified three potential regions within the C-terminal arm: a flexible loop (1047-1052), a β clamp (1053-1061), and a hydrophobic hairpin (1062-1066). A mutant protein lacking residues 1052-1066 failed to cosediment with acidic phospholipid vesicles at a physiologic pH (Bakolitsa et al., 1999) . This observation, the hydrophobic nature of the vinculin hairpin tail, and the possibility that tryptophans may orient proteins towards membranes, or perhaps play a role in the bilayer insertion process (Wallace and Janes, 1999) , led Bakolitsa et al to propose that the last five amino acid residues in vinculin, Thr-Pro-Trp-Tyr-Gln (TPWYQ), are inserted into membranes (Bakolitsa et al., 1999) . Whether this observation holds true or not for the intact protein is a question that needs to be addressed in more detail since Johnson et al (Johnson et al., 1998) have 24 shown that native vinculin does not spontaneously associate with acidic phospholipid vesicles under physiologic conditions. The phosphorylation of vinculin on residue 1065 may generate a transient conformation that is more favorable for membrane recognition than the unphosphorylated tail, particularly if, as our data suggest, this phosphorylation affects head-tail interactions. One intriguing possibility is that the phosphorylation may help unmask residues 916-970 shown to interact with, and insert into, acidic phospholipids (Johnson et al., 1998) . On the other hand, it is also possible that the phosphorylation creates a deliberate obstacle for the membrane insertion step, and thus serves to regulate the membrane binding activity of vinculin, and/or the targeting of vinculin to specific sites, where it may help facilitate the assembly of actin filaments. As a follow up to this notion, it is also possible to envision that the recruitment of vinculin to specific sites is regulated by a phosphatase that can rapidly dephosphorylate vinculin thus rendering the phosphorylation a transient event. This may explain why the phosphorylation of vinculin in COS-7 cells is not detected unless the cells are pretreated with
vanadate. Such a model would also imply that the activation state of vinculin is tightly regulated by Src kinases and a counter acting phosphatase(s).
α-actinin (Izaguirre et al., 1999) , and as shown here, vinculin, undergo robust tyrosine phosphorylation in spread platelets. The significance of these tyrosine phosphorylation events is clearly not limited to platelets (von Wichert et al., 2003) but rather is easier to detect in platelets than in other types. Why is that the case? It appears that platelet spreading is an "all-out" process. Since platelet spreading is an irreversible process, platelets can afford to unleash robust tyrosine phosphorylation of proteins that are only transiently or sparsely phosphorylated in other cell types thus limiting their detection. Considering the large number of proteins that are phosphorylated on tyrosine in spread platelets this system should prove to be informative in efforts to dissect events regulating focal adhesion assembly. His-vinculin tail (His-tail) and -head (His-head) domain proteins were incubated for 15 min in kinase buffer containing 10 µCi of (γ-33 P)ATP without (lanes 1 and 3) or with c-Src (7.5 units per reaction) (lanes 2 and 4). Reaction products were resolved by SDS-PAGE and transferred to a PVDF membrane. Incorporation of (γ-33 P)ATP was detected by autoradiogaphy (Autorad). The membrane was subsequently probed with the mAb to vinculin and to His to confirm, respectively, equal loading of the head and tail domain proteins. actin (1.6 µM) in polymerization buffer. An aliquot was removed from each sample prior to the sedimentation (lane 1; Total). The samples then were subject to centrifugation at 100,000 x g for 30 min. The supernatnats were removed and the pellets were resuspended in sample buffer.
Equal volumes from each sample were analyzed by SDS-PAGE and Western blotting with the indicated antibodies. 
